A detailed history of Squarepoint Ops LLC transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 16,227 shares of PLSE stock, worth $296,954. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,227
Holding current value
$296,954
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.83 - $21.83 $175,738 - $354,235
16,227 New
16,227 $284,000
Q2 2023

Aug 14, 2023

BUY
$3.67 - $8.64 $49,651 - $116,890
13,529 New
13,529 $97,000
Q3 2020

Nov 16, 2020

SELL
$9.27 - $13.14 $401,187 - $568,672
-43,278 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$6.23 - $13.09 $269,621 - $566,509
43,278 New
43,278 $453,000
Q1 2018

May 15, 2018

SELL
$12.67 - $24.69 $122,772 - $239,246
-9,690 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$18.81 - $30.33 $182,268 - $293,897
9,690
9,690 $229,000

Others Institutions Holding PLSE

About Pulse Biosciences, Inc.


  • Ticker PLSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,125,900
  • Market Cap $679M
  • Description
  • Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...
More about PLSE
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.